In addition, Peter et al., found that miR-107 levels in the temporal lobe were lower in patients with early AD, and there was a negative correlation between miR-107 and BACE1 mRNA levels (Nelson and Wang, 2010). This evidence concerns the gene BACE1 and Alzheimer disease.